GIMV is a Belgium based public investment company focused on private equity and venture capital investments in tech-based businesses. GIMV's private equity practice operates through its Corporate Investment unit and targets management buyouts, buy-ins, and growth capital financings of companies with annual sales between EUR15 and EUR150 million. For buyout opportunities GIMV generally takes a majority stake in businesses and for growth capital needs, GIMV takes a minority position. GIMV does not invest in publicly held companies or turnaround situations. GIMV's geographic focus is within Belgium, Netherlands, Germany, and France. GIMV also invests in Russia through Eagle Capital Partners, a partnership with KBC Private Equity. GIMV was formed in 1980 and is headquartered in Antwerp with additional offices in The Hague, Frankfurt, Munich, and Paris.
Join Mergr to view the latest updates and news from Belgium-based GIMV.
In the last 3 years, GIMV has acquired 5 companies. It has also invested in 10 others.
GIMV’s most common sectors for investment are software (12%) and life science (12%). The Firm’s most common investment types include buyout (lbo, mbo, mbi) (35%) and venture (27%). In total, GIMV has invested in 4 US states and 11 different countries. Its largest (disclosed) acquisition occurred in 2010 when it acquired OneDirect Group for $15M.
In the last 3 years, GIMV has exited 12 companies. The Firm’s most common exit type is trade sale (55%). GIMV’s largest (disclosed) exit occurred in 2013 when it sold Astex Pharmaceuticals for $886M.
Join Mergr to view GIMV’s full profile and discover more large private equity firms just like it.
No obligation. Cancel anytime.